Your browser is no longer supported. Please, upgrade your browser.
Settings
BDSI BioDelivery Sciences International, Inc. daily Stock Chart
BDSI [NASD]
BioDelivery Sciences International, Inc.
Index- P/E- EPS (ttm)-0.58 Insider Own3.30% Shs Outstand88.48M Perf Week3.97%
Market Cap393.74M Forward P/E19.78 EPS next Y0.23 Insider Trans-60.91% Shs Float85.38M Perf Month20.92%
Income-40.90M PEG- EPS next Q-0.02 Inst Own71.10% Short Float4.10% Perf Quarter-1.98%
Sales81.60M P/S4.83 EPS this Y-883.40% Inst Trans22.56% Short Ratio3.66 Perf Half Y-5.92%
Book/sh0.79 P/B5.63 EPS next Y237.50% ROA-32.70% Target Price7.42 Perf Year56.14%
Cash/sh0.65 P/C6.88 EPS next 5Y25.00% ROE-102.80% 52W Range2.55 - 5.37 Perf YTD20.27%
Dividend- P/FCF- EPS past 5Y13.50% ROI-29.10% 52W High-17.18% Beta0.24
Dividend %- Quick Ratio2.10 Sales past 5Y37.40% Gross Margin79.40% 52W Low74.51% ATR0.18
Employees164 Current Ratio2.30 Sales Q/Q143.40% Oper. Margin-8.20% RSI (14)62.88 Volatility3.11% 4.82%
OptionableYes Debt/Eq0.88 EPS Q/Q19.30% Profit Margin-50.00% Rel Volume0.32 Prev Close4.45
ShortableYes LT Debt/Eq0.88 EarningsAug 08 AMC Payout- Avg Volume957.92K Price4.45
Recom1.60 SMA209.93% SMA506.47% SMA2003.25% Volume182,737 Change0.00%
Mar-20-19Initiated SunTrust Buy $7
Jan-31-19Resumed Janney Buy $5
Jan-26-18Initiated Seaport Global Securities Buy $5
Aug-14-17Resumed Cantor Fitzgerald Overweight $4.50
Aug-10-17Reiterated H.C. Wainwright Buy $4 → $5
May-26-17Initiated H.C. Wainwright Buy $4
May-17-17Upgrade Cantor Fitzgerald Neutral → Overweight
May-12-16Reiterated Piper Jaffray Overweight $6 → $4
May-11-16Downgrade Cantor Fitzgerald Buy → Hold
May-04-16Reiterated FBR Capital Outperform $12 → $9
Mar-14-16Reiterated Laidlaw Buy $17 → $11
Mar-11-16Reiterated FBR Capital Outperform $13 → $12
Feb-08-16Initiated Piper Jaffray Overweight
Nov-10-15Reiterated FBR Capital Mkt Perform $17 → $14
Nov-04-15Initiated Cantor Fitzgerald Buy
May-12-15Reiterated Cantor Fitzgerald Buy $17 → $12
May-11-15Reiterated ROTH Capital Buy $16 → $14
Apr-22-15Resumed Piper Jaffray Overweight
Apr-02-15Initiated FBR Capital Outperform $19
Mar-31-15Reiterated ROTH Capital Buy $18 → $16
Aug-16-19 01:41AM  Edited Transcript of BDSI earnings conference call or presentation 8-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-09-19 11:55PM  BioDelivery Sciences International, Inc. (BDSI) Q2 2019 Earnings Call Transcript Motley Fool +7.94%
10:17AM  BioDelivery (BDSI) Earnings & Sales Beat Estimates in Q2 Zacks
Aug-08-19 04:05PM  BioDelivery Sciences Reports Strong Second Quarter 2019 Results and Raises Net Sales Expectations GlobeNewswire +6.61%
01:03PM  How Much Are BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Insiders Taking Off The Table? Simply Wall St.
Aug-01-19 10:33AM  Will BioDelivery Sciences International (BDSI) Report Negative Earnings Next Week? What You Should Know Zacks +5.12%
Jul-30-19 07:45AM  BioDelivery Sciences to Report Second Quarter 2019 Financial Results and Host Conference Call on August 8, 2019 GlobeNewswire
Jul-29-19 01:47PM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating BioDelivery Sciences International, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Jul-25-19 10:15AM  Why a career Triangle pharma executive is bringing a Georgia spin-out to the region American City Business Journals
Jul-17-19 04:30AM  3 Small-Caps That Look Like Bargains at Current Trading Levels TheStreet.com
Jul-09-19 08:00AM  BioDelivery Sciences Announces Further Improved Insurance Coverage for BELBUCA® GlobeNewswire
Jul-03-19 02:19PM  Perrigo Completes Ranir Acquisition, Raises '19 Guidance Zacks
11:46AM  Top Ranked Momentum Stocks to Buy for July 3rd Zacks
10:22AM  Amarin (AMRN) Issues Update on Q2 Sales, Raises '19 Guidance Zacks
Jun-28-19 02:19PM  18 Stocks Joining The Russell Indices Benzinga +5.68%
11:32AM  Zacks.com featured highlights include: BioDelivery, Ciena, United States and Molina Zacks
Jun-27-19 09:18AM  Focus on 4 Liquid Picks on the Top Rung for Robust Returns Zacks
Jun-25-19 09:00AM  What Makes BioDelivery (BDSI) a New Strong Buy Stock Zacks
Jun-24-19 08:00AM  BioDelivery Sciences Expands Upon Report from Pain Management Task Force GlobeNewswire
Jun-21-19 10:37AM  The Zacks Analyst Blog Highlights: Middlesex Water, Atlantic Power, NexPoint Residential Trust, Illumina and BioDelivery Sciences International Zacks
Jun-20-19 09:18AM  5 Top Rate-Sensitive Stocks to Buy Amid Fed's Rate Cut Hints Zacks
08:00AM  BioDelivery Sciences Named to the Russell 3000® Index GlobeNewswire
Jun-19-19 08:43PM  Heres What Hedge Funds Think About BioDelivery Sciences International, Inc. (BDSI) Insider Monkey
Jun-05-19 09:30AM  Why Is BioDelivery (BDSI) Down 12.3% Since Last Earnings Report? Zacks
May-31-19 08:33AM  Triangle company uses new financial strength to lock down favorable loan American City Business Journals
May-29-19 04:10PM  BioDelivery Sciences Announces Upcoming Investor Conference Presentations GlobeNewswire
May-28-19 04:10PM  BioDelivery Sciences Strengthens Financial Position with Debt Refinancing GlobeNewswire
07:46AM  Can You Imagine How Chuffed BioDelivery Sciences International's (NASDAQ:BDSI) Shareholders Feel About Its 108% Share Price Gain? Simply Wall St.
May-23-19 09:19AM  The Zacks Analyst Blog Highlights: Cambrex, Innoviva, Celgene, BioDelivery Sciences International and Unity Biotechnology Zacks
May-22-19 07:21AM  5 Biotech Stocks to Gain From Trade Deal Rally on the Horizon Zacks
May-21-19 09:00AM  All You Need to Know About BioDelivery (BDSI) Rating Upgrade to Buy Zacks
May-14-19 12:50AM  Edited Transcript of BDSI earnings conference call or presentation 6-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-07-19 09:40AM  BioDelivery (BDSI) Stock Up on Q1 Earnings and Sales Beat Zacks
May-06-19 10:03PM  BioDelivery Sciences International, Inc. (BDSI) Q1 2019 Earnings Call Transcript Motley Fool
06:45PM  BioDelivery Sciences International (BDSI) Reports Q1 Loss, Tops Revenue Estimates Zacks
05:40PM  BioDelivery: 1Q Earnings Snapshot Associated Press
04:05PM  BioDelivery Sciences Reports Strong First Quarter 2019 Results and Raises BELBUCA® Full-Year Expectations GlobeNewswire
May-02-19 10:32AM  Will BioDelivery Sciences International (BDSI) Report Negative Q1 Earnings? What You Should Know Zacks
10:11AM  What's in Store for BioDelivery (BDSI) This Earnings Season? Zacks
Apr-25-19 04:30PM  BioDelivery Sciences to Report First Quarter 2019 Financial Results GlobeNewswire
Apr-17-19 09:00AM  What Makes BioDelivery (BDSI) a New Buy Stock Zacks
Apr-13-19 09:30AM  BioDelivery (BDSI) Up 7.8% Since Last Earnings Report: Can It Continue? Zacks
Apr-11-19 10:45AM  BDSI expects $50 million in latest public offering American City Business Journals
09:34AM  BioDelivery (BDSI) Buys US Rights to Pain Drug for $30M Zacks
09:29AM  BioDelivery Sciences International, Inc. Announces Pricing of Public Offering of Common Stock GlobeNewswire
07:48AM  The Daily Biotech Pulse: NASH Cheer For Intercept, Gilead Layoffs, BioDelivery Licenses Constipation Drug Benzinga
07:25AM  BDSI announces public offering after paying $30M for drug rights American City Business Journals
Apr-10-19 04:07PM  BioDelivery Sciences International, Inc. Announces Proposed Underwritten Public Offering of Common Stock GlobeNewswire
04:06PM  BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic® GlobeNewswire
Mar-27-19 05:45PM  BioDelivery Sciences International (BDSI) Dips More Than Broader Markets: What You Should Know Zacks
Mar-22-19 06:24PM  Lifshitz & Miller LLP Announces Investigation of Alta Mesa Resources, Inc., American Renal Associates LLC, Belden, Inc., BioDelivery Sciences, Inc., Blue Valley Bank Corp., Bridgepoint Education, Inc., and Care.com, Inc. PR Newswire
08:25AM  Edited Transcript of BDSI earnings conference call or presentation 14-Mar-19 8:30pm GMT Thomson Reuters StreetEvents
Mar-21-19 05:45PM  BioDelivery Sciences International (BDSI) Gains But Lags Market: What You Should Know Zacks
Mar-19-19 02:26PM  Catalyst (CPRX) Reports Wider Q4 Loss, Focuses on Firdapse Zacks
Mar-18-19 06:44PM  Bristol-Myers & Pfizer Release Phase IV Data on Eliquis Zacks
Mar-15-19 10:23AM  BioDelivery (BDSI) Q4 Earnings In Line, Sales Beat, Stock Up Zacks +7.79%
Mar-14-19 08:20PM  Biodelivery Sciences International Inc (BDSI) Q4 2018 Earnings Conference Call Transcript Motley Fool
07:45PM  BioDelivery: 4Q Earnings Snapshot Associated Press
04:05PM  BioDelivery Sciences Reports Strong 2018 Results and 2019 Expectations ACCESSWIRE
02:30PM  BioDelivery Sciences International, Inc. to Host Earnings Call ACCESSWIRE
Mar-13-19 12:50PM  Aerie (AERI) Receives FDA Nod for Rocklatan to Treat Glaucoma Zacks
Mar-12-19 10:58AM  BioDelivery Sciences Investigated by Block & Leviton LLP For Violations of Federal Securities Laws GlobeNewswire -6.03%
09:59AM  Alnylam Files Application for Hypertension Candidate in UK Zacks
Mar-11-19 02:38PM  What Kind Of Shareholder Appears On The BioDelivery Sciences International, Inc.s (NASDAQ:BDSI) Shareholder Register? Simply Wall St.
10:35AM  AMAG's Stock Down as Pregnancy Drug Fails in PROLONG Study Zacks
10:00AM  What Makes BioDelivery Sciences International (BDSI) a Strong Momentum Stock: Buy Now? Zacks
09:56AM  Will the Decade-Old Bull Market Momentum Last? 5 Picks Zacks
Mar-05-19 04:36PM  What's in Store for BioSpecifics (BSTC) This Earnings Season? Zacks
04:06PM  What's in the Cards for Corbus (CRBP) This Earnings Season? Zacks
08:44AM  REGENXBIO (RGNX) in Focus: Stock Moves 5.1% Higher Zacks
Mar-04-19 11:40PM  Champions Oncology (CSBR) Q3 Earnings: What's in Store? Zacks
11:34PM  What's in the Cards for Novavax (NVAX) This Earnings Season? Zacks
08:58AM  What's in the Cards for Aeterna (AEZS) This Earnings Season? Zacks
Mar-01-19 02:20PM  Endo (ENDP) Q4 Earnings & Revenues Beat Estimates, Shares Up Zacks
11:59AM  Amicus (FOLD) Reports Wider-than-Expected-Loss for 2018 Zacks
10:27AM  The Meet Group (MEET) to Report Q4 Earnings: What's in Store? Zacks
Feb-28-19 11:12AM  Horizon Pharma's (HZNP) Stock Up on Q4 Earnings & Sales Beat Zacks
08:52AM  Zacks.com featured expert Kevin Matras highlights: First, Clearfield, BioDelivery Sciences International, MGIC Investment and Kratos Defense & Security Solutions Zacks
Feb-27-19 07:19AM  Editas (EDIT) to Report Q4 Earnings: What's in the Cards? Zacks
07:13AM  Jazz Pharma (JAZZ) Q4 Earnings & Sales Beat, Stock Up 8% Zacks
06:24AM  5 Affordable Breakout Stocks for Superlative Returns Zacks
Feb-25-19 07:57AM  What's in the Cards for Nektar (NKTR) This Earnings Season? Zacks
Feb-22-19 04:53PM  Amgen Starts Phase III Enrollment for Heart Failure Drug Zacks +5.71%
04:43PM  What's in Store for Vericel (VCEL) This Earnings Season? Zacks
04:36PM  What's in Store for Teladoc's (TDOC) Q4 Earnings? Zacks
02:46PM  bluebird (BLUE) Q4 Earnings Beat Estimates, Revenues Up Y/Y Zacks
09:23AM  BioMarin (BMRN) Q4 Earnings & Sales Miss, Shares Decline Zacks
Feb-21-19 05:45PM  BioDelivery Sciences International (BDSI) Dips More Than Broader Markets: What You Should Know Zacks
09:34AM  Agios' Tibsovo Gets FDA Priority Review in First-Line Cancer Zacks
07:45AM  BioDelivery Sciences to Report Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
Feb-20-19 09:45AM  Key Factors to Know Ahead of TransEnterix (TRXC) Q4 Earnings Zacks
09:12AM  3 Small Biotechs to Watch as Earnings Season Winds Down TheStreet.com
07:41AM  Ultragenyx (RARE) Posts Narrower-Than-Expected Loss in Q4 Zacks
Feb-19-19 10:07AM  What's in Store for Sangamo (SGMO) This Earnings Season? Zacks
07:20AM  Factors of Influence in 2019, Key Indicators and Opportunity within Procter & Gamble, Hertz Global, NN, Omnicell, BioDelivery Sciences International, and Movado Group New Research Emphasizes Economic Growth GlobeNewswire
Feb-18-19 08:16AM  What's in the Cards for Amarin (AMRN) This Earnings Season? Zacks
Feb-15-19 02:25PM  Agios (AGIO) Q4 Earnings Beat, Tibsovo Sales Push Up Stock Zacks
10:29AM  Acorda (ACOR) Q4 Earnings and Revenues Surpass Estimates Zacks
08:54AM  Key Factors Likely to Shape CVS Health's (CVS) Q4 Earnings Zacks
Feb-14-19 10:45AM  The Zacks Analyst Blog Highlights: BioDelivery, Cytokinetics, Celldex, Aduro and Aeterna Zacks
BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug-delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; BUNAVAIL, a buprenorphine and naloxone buccal film to treat opioid dependence; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in opioid tolerant adult patients with cancer. The company also develops buprenorphine extended release injection, an injectable microparticle formulation of buprenorphine for the treatment of opioid dependence and chronic pain. BioDelivery Sciences International, Inc. was founded in 1997 and is headquartered in Raleigh, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Watson W. MarkDirectorAug 13Option Exercise0.0024,739035,979Aug 15 04:29 PM
Davis Todd CDirectorAug 13Option Exercise0.0018,1230437,914Aug 15 04:27 PM
KOTLER KEVINDirectorAug 13Option Exercise0.0018,12304,300,066Aug 15 04:28 PM
Greenleaf PeterDirectorAug 13Option Exercise0.0021,144024,788Aug 15 04:25 PM
ODONNELL FRANCIS E JRDirectorAug 01Sale3.828,00030,560596,754Aug 02 04:06 PM
ODONNELL FRANCIS E JRDirectorJul 01Sale4.688,00037,440604,754Jul 03 06:00 PM
Sirgo Mark ADirectorJun 25Sale4.3990,706398,1992,031,714Jun 27 06:00 PM
Sirgo Mark ADirectorJun 12Sale4.21177,495747,2542,122,420Jun 13 06:00 PM
Sirgo Mark ADirectorJun 11Option Exercise3.6884,717311,8172,607,172Jun 13 06:00 PM
Sirgo Mark ADirectorJun 11Sale4.22307,2571,296,6252,299,915Jun 13 06:00 PM
ODONNELL FRANCIS E JRDirectorJun 03Sale4.328,00034,560612,754Jun 05 06:00 PM
Broadfin Healthcare Master FunDirectorMay 10Sale5.001,800,0009,000,0004,281,943May 14 04:58 PM
Cukier HermChief Executive OfficerMay 09Sale4.928604,23136,381May 10 06:00 PM
Cukier HermChief Executive OfficerMay 08Sale5.0729,425149,18537,421May 10 06:00 PM
ODONNELL FRANCIS E JRDirectorMay 01Sale4.778,00038,160598,254May 03 06:00 PM
Broadfin Healthcare Master FunDirectorApr 11Sale5.002,000,00010,000,0004,281,943Apr 15 04:14 PM
ODONNELL FRANCIS E JRDirectorApr 01Sale5.198,00041,520606,254Apr 03 06:00 PM
Sirgo Mark ADirectorMar 21Sale5.209,05047,0602,499,955Mar 22 06:00 PM
ODONNELL FRANCIS E JRDirectorMar 21Sale5.2171,690373,505614,254Mar 22 06:01 PM
ODONNELL FRANCIS E JRDirectorMar 20Option Exercise0.0077,5000661,187Mar 22 06:01 PM
Plesha Scott M.See RemarksMar 20Option Exercise0.0029,1660261,503Mar 22 06:02 PM
ODONNELL FRANCIS E JRDirectorMar 01Option Exercise0.0046,0000544,187Mar 01 06:43 PM
Plesha Scott M.See RemarksMar 01Option Exercise0.0011,6660224,004Mar 01 06:46 PM
ODONNELL FRANCIS E JRDirectorMar 01Sale5.0723,000116,610521,187Mar 01 06:43 PM
Sirgo Mark ADirectorJan 02Option Exercise3.059,17527,9842,498,717Jan 04 06:02 PM
Sirgo Mark ADirectorJan 02Sale3.579,17532,7552,489,542Jan 04 06:02 PM
ODONNELL FRANCIS E JRDirectorJan 02Sale3.648,00029,120506,187Jan 04 06:01 PM
Sirgo Mark ADirectorDec 27Sale2.9110,00029,1002,489,542Dec 28 06:07 PM
De Paolantonio Ernest RobertCFO, Secretary and TreasurerDec 04Sale3.7916,16161,250140,548Dec 06 06:01 PM
ODONNELL FRANCIS E JRDirectorDec 03Sale3.728,00029,760514,187Dec 04 06:00 PM
ODONNELL FRANCIS E JRDirectorNov 01Sale3.848,00030,720522,187Nov 02 06:00 PM
ODONNELL FRANCIS E JRDirectorOct 01Sale2.758,00022,000530,187Oct 03 06:00 PM
ODONNELL FRANCIS E JRDirectorSep 13Option Exercise0.00108,5000569,121Sep 14 06:00 PM
ODONNELL FRANCIS E JRDirectorSep 13Sale2.8484,372239,616538,187Sep 14 06:00 PM
ODONNELL FRANCIS E JRDirectorSep 12Option Exercise0.00133,3330520,482Sep 14 06:00 PM
ODONNELL FRANCIS E JRDirectorSep 12Sale2.8366,667188,668453,815Sep 14 06:00 PM